Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity.

Literature DB >> 10473460

British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity.

B M Psaty, C D Furberg.

Abstract

Entities: Disease

Mesh：

Year: 1999 PMID： 10473460 PMCID： PMC1116478 DOI： 10.1136/bmj.319.7210.589

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

12 in total

1. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

Authors: B M Psaty; N S Weiss; C D Furberg; T D Koepsell; D S Siscovick; F R Rosendaal; N L Smith; S R Heckbert; R C Kaplan; D Lin; T R Fleming; E H Wagner
Journal: JAMA Date: 1999-08-25 Impact factor: 56.272

2. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

Authors:
Journal: J Hypertens Date: 1999-02 Impact factor: 4.844

3. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Authors: B M Psaty; N L Smith; D S Siscovick; T D Koepsell; N S Weiss; S R Heckbert; R N Lemaitre; E H Wagner; C D Furberg
Journal: JAMA Date: 1997-03-05 Impact factor: 56.272

Review 4. Calcium antagonists, appropriate therapy for diabetic patients with hypertension?

Authors: K Malmberg; L Rydén; H Wedel
Journal: Eur Heart J Date: 1998-09 Impact factor: 29.983

5. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

Authors: B R Davis; J A Cutler; D J Gordon; C D Furberg; J T Wright; W C Cushman; R H Grimm; J LaRosa; P K Whelton; H M Perry; M H Alderman; C E Ford; S Oparil; C Francis; M Proschan; S Pressel; H R Black; C M Hawkins
Journal: Am J Hypertens Date: 1996-04 Impact factor: 2.689

6. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.

Authors: R O Estacio; B W Jeffers; W R Hiatt; S L Biggerstaff; N Gifford; R W Schrier
Journal: N Engl J Med Date: 1998-03-05 Impact factor: 91.245

7. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

Authors: P Tatti; M Pahor; R P Byington; P Di Mauro; R Guarisco; G Strollo; F Strollo
Journal: Diabetes Care Date: 1998-04 Impact factor: 19.112

8. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina).

Authors: R J Gibbons; K Chatterjee; J Daley; J S Douglas; S D Fihn; J M Gardin; M A Grunwald; D Levy; B W Lytle; R A O'Rourke; W P Schafer; S V Williams
Journal: Circulation Date: 1999-06-01 Impact factor: 29.690

9. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors:
Journal: Arch Intern Med Date: 1997-11-24

British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity.

1. Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

2. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

3. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.

Review 4. Calcium antagonists, appropriate therapy for diabetic patients with hypertension?

5. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

6. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.

7. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

9. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Review 10. The rationale for differing national recommendations for the treatment of hypertension.

1. Management of hypertension. Ideal body weight is not realistic goal for lifestyle intervention.

2. Meeting the National Service Framework for coronary heart disease: which patients have untreated high blood pressure?

3. The wrong tool for the job: diabetes public health programs and practice guidelines.

4. Clinical practice guidelines: towards better quality guidelines and increased international collaboration.